Thursday, October 15, 2026
ExploreSearch
Finance Via News
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· March 25, 2026

Hercules Capital (HTGC) Faces Securities Class Action After Short Seller Claims Company Copied Google Ventures, Questions Marks and PIKs -- Hagens Berman

View original at globenewswire.com
Hercules Capital (HTGC) Faces Securities Class Action After Short Seller Claims Company Copied Google Ventures, Questions Marks and PIKs -- Hagens Berman SAN FRANCISCO, March 25, 2026 (GLOBE NEWSWIRE) -- Hercules Capital (NYSE: HTGC) faces a securities class action lawsuit which seeks to represent investors who purchas…
Opening lines of the source · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Hercules overstated or misrepresented its portfolio valuations and its net asset value

    60% confidence

  • About 35% of the value of Hercules' loan portfolio is software-exposed

    60% confidence

  • Hercules' finance team was small and overstretched with few checks in place compared to other BDCs

    60% confidence

  • A growing share of Hercules' income is phantom because of the company's increasing usage of payment-in-kind loans

    60% confidence

  • Hercules has assured investors about the robust origination process for sourcing potential investments and the effectiveness of its due diligence process

    60% confidence

  • Investigating whether Hercules misled investors about its sourcing, underwriting, marks, PIKs, and ultimately its NAV

    60% confidence

  • Hercules overstated the due diligence with which it conducted its deal sourcing and loan origination process, overstated the due diligence in its portfolio valuation process, and reported misclassified portfolio investments

    60% confidence

  • Hercules' deal sourcing process essentially amounted to going on the website for Google Ventures and just seeing what they invest in and copying it

    60% confidence

  • Despite billions worth of software debt across the industry falling into distressed territory, Hercules still marks its software book at 100 cents on the dollar

    60% confidence
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Clinical Catalyst Season: Big-Pharma Data Flow, Regulatory Milestones, and a Thin AI-Drug Fringe
October 2026 conferences (EASD, IGCS, NACFC, HFSA) are producing a dense run of late-stage readouts from Novo Nordisk, Lilly, Roche, Bayer, Vertex and Galderma. Regulatory milestones are scheduled behind them: the ivonescimab BLA PDUFA date on 2026-11-14, FDA acceptance of Roche's vamikibart BLA, and Scholar Rock's EMA resubmission. The AI-and-finance angle is peripheral. It consists of the AI-designed drug Rentosertib and QAIAx, a speculative microcap whose trial claims (the QIII pilot, anticipated 2027-01-01, and a patent update) are forecasts and filings rather than data, so they warrant skepticism.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,375 source documents archived
Query this data → isubstrate.com
Hercules Capital (HTGC) Faces Securities Class Action After Short Seller Claims Company Copied Google Ventures, Questions Marks and PIKs -- Hagens Berman — Source | Via News | Finance Via News